182 related articles for article (PubMed ID: 23069197)
1. Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life.
Mrozek-Budzyn D; Majewska R; Kieltyka A; Augustyniak M
Neurotoxicol Teratol; 2012; 34(6):592-7. PubMed ID: 23069197
[TBL] [Abstract][Full Text] [Related]
2. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
[TBL] [Abstract][Full Text] [Related]
3. Early exposure to thimerosal-containing vaccines and children's cognitive development. A 9-year prospective birth cohort study in Poland.
Mrozek-Budzyn D; Majewska R; Kiełtyka A
Eur J Pediatr; 2015 Mar; 174(3):383-91. PubMed ID: 25185528
[TBL] [Abstract][Full Text] [Related]
4. Fish consumption in pregnancy, cord blood mercury level and cognitive and psychomotor development of infants followed over the first three years of life: Krakow epidemiologic study.
Jedrychowski W; Perera F; Jankowski J; Rauh V; Flak E; Caldwell KL; Jones RL; Pac A; Lisowska-Miszczyk I
Environ Int; 2007 Nov; 33(8):1057-62. PubMed ID: 17643489
[TBL] [Abstract][Full Text] [Related]
5. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopment of Amazonian children exposed to ethylmercury (from Thimerosal in vaccines) and methylmercury (from fish).
Marques RC; Abreu L; Bernardi JVE; Dórea JG
Environ Res; 2016 Aug; 149():259-265. PubMed ID: 26774584
[TBL] [Abstract][Full Text] [Related]
7. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
[TBL] [Abstract][Full Text] [Related]
9. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
10. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
Marques RC; Dórea JG; Manzatto AG; Bastos WR; Bernardi JV; Malm O
Acta Paediatr; 2007 Jun; 96(6):864-8. PubMed ID: 17465985
[TBL] [Abstract][Full Text] [Related]
11. Prenatal lead and cadmium co-exposure and infant neurodevelopment at 6 months of age: the Mothers and Children's Environmental Health (MOCEH) study.
Kim Y; Ha EH; Park H; Ha M; Kim Y; Hong YC; Kim EJ; Kim BN
Neurotoxicology; 2013 Mar; 35():15-22. PubMed ID: 23220728
[TBL] [Abstract][Full Text] [Related]
12. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later.
Barile JP; Kuperminc GP; Weintraub ES; Mink JW; Thompson WW
J Pediatr Psychol; 2012; 37(1):106-18. PubMed ID: 21785120
[TBL] [Abstract][Full Text] [Related]
13. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
Marques RC; Dórea JG; Bernardi JV
Acta Paediatr; 2010 Jun; 99(6):934-9. PubMed ID: 20003103
[TBL] [Abstract][Full Text] [Related]
14. Stability of the mental and motor Bayley Scales of Infant Development (2nd ed.) in infants over first three years of life.
Augustyniak M; Mrozek-Budzyn D; Kieltyka A; Majewska R
Przegl Epidemiol; 2013; 67(3):483-6, 581-4. PubMed ID: 24340565
[TBL] [Abstract][Full Text] [Related]
15. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
Geier D; Geier MR
Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
[TBL] [Abstract][Full Text] [Related]
17. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Parker SK; Schwartz B; Todd J; Pickering LK
Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
[TBL] [Abstract][Full Text] [Related]
18. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.
Dórea JG
Clin Chim Acta; 2010 Nov; 411(21-22):1580-6. PubMed ID: 20638374
[TBL] [Abstract][Full Text] [Related]
19. Milestone achievement and neurodevelopment of rural Amazonian toddlers (12 to 24 months) with different methylmercury and ethylmercury exposure.
Dórea JG; Marques RC; Abreu L
J Toxicol Environ Health A; 2014; 77(1-3):1-13. PubMed ID: 24555642
[TBL] [Abstract][Full Text] [Related]
20. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
Young HA; Geier DA; Geier MR
J Neurol Sci; 2008 Aug; 271(1-2):110-8. PubMed ID: 18482737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
